Top

Published in:

01-11-2012 | Stanford Multidisciplinary Seminars

Acute Fulminant Hepatic Failure Associated with Parvovirus B19 Infection in an Immunocompetent Adult

Authors: Robert J. Huang, Brandon C. Varr, George Triadafilopoulos

Published in: Digestive Diseases and Sciences | Issue 11/2012

Excerpt

A previously healthy 21-year-old female presented with epigastric pain, nausea, vomiting, arthralgias, and decreased appetite. Three weeks before presentation, she had developed cough, fevers, chills, and coryza immediately following a similar illness in her 4-year-old daughter. Although in the interval her respiratory symptoms had resolved, she continued to experience fevers, chills, and arthralgias. Three days before presentation she began to notice mid-epigastric pain, severe headache, profound nausea, and non-bilious, non-bloody vomiting. She denied other sick exposures, alcohol use, illicit drug use, or recent travel history. …

Young NS, Brown KE. Parvovirus B19. New Engl J Med. 2004;350:586–597. doi:10.1056/NEJMra030840.PubMedCrossRef

Kim BJ, Yoo KH, Li K, Kim MN. Parvovirus B19 infection associated with acute hepatitis in infant. Pediatr Infect Dis J. 2009;28:667. doi:10.1097/INF.0b013e3181a645bd.PubMedCrossRef

Sokal EM, Melchior M, Cornu C, et al. Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet. 1998;352:1739–1741. doi:10.1016/S0140-6736(98)06165-0.PubMedCrossRef

Yoto Y, Kudoh T, Asanuma H, et al. Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection. Lancet. 1994;344:624–625.PubMedCrossRef

Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet. 1996;347:868–869.PubMedCrossRef

Dwivedi M, Manocha H, Tiwari S, Tripathi G, Dhole TN. Coinfection of parvovirus B19 with other hepatitis viruses leading to fulminant hepatitis of unfavorable outcome in children. Pediatr Infect Dis J. 2009;28:649–650. doi:10.1097/INF.0b013e318198d05c.PubMedCrossRef

Hsu TC, Chen TY, Lin MC, Tzang BS, Tsay GJ. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. J Gastroenterol Hepatol. 2005;20:733–738. doi:10.1111/j.1440-1746.2005.03815.x.PubMedCrossRef

Toan NL, le Song H, Kremsner PG, et al. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J Hepatol. 2006;45:361–369. doi:10.1016/j.jhep.2006.03.013.PubMedCrossRef

Wong S, Young NS, Brown KE. Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis. 2003;187:1581–1586. doi:10.1086/374781.PubMedCrossRef

10.

Hillingso JG, Jensen IP, Tom-Petersen L. Parvovirus B19 and acute hepatitis in adults. Lancet. 1998;351:955–956. doi:10.1016/S0140-6736(05)60609-5.PubMed

11.

Ho JK, Tha SP, Coupland R, et al. Parvovirus B19 in an immunocompetent adult patient with acute liver failure: an under diagnosed cause of acute non-A–E viral hepatitis. Can J Gastroenterol. 2005;19:161–162.PubMed

12.

Krygier DS, Steinbrecher UP, Petric M, et al. Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation. WJG. 2009;15:4067–4069.PubMedCrossRef

13.

Pardi DS, Romero Y, Mertz LE, Douglas DD. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature. Am J Gastroenterol. 1998;93:468–470. doi:10.1111/j.1572-0241.1998.468_1.x.PubMedCrossRef

14.

Tsuda H. Liver dysfunction caused by parvovirus B19. Am J Gastroenterol. 1993;88:1463.PubMed

15.

Sun L, Zhang JC, Jia ZS. Association of parvovirus B19 infection with acute icteric hepatitis in adults. Scand J Infect Dis. 2011;43:547–549. doi:10.3109/00365548.2011.554856.PubMedCrossRef

16.

Hatakka A, Klein J, He R, Piper J, Tam E, Walkty A. Acute hepatitis as a manifestation of parvovirus B19 infection. J Clin Microbiol. 2011;49:3422–3424. doi:10.1128/JCM.00575-11.PubMedCentralPubMedCrossRef

17.

Diaz F, Collazos J. Hepatic dysfunction due to parvovirus B19 infection. J Infect Chemother Off J Jap Soci Chemother. 2000;6:63–64. doi:10.1007/s101560000023.

18.

Poole BD, Karetnyi YV, Naides SJ. Parvovirus B19-induced apoptosis of hepatocytes. J Virol. 2004;78:7775–7783. doi:10.1128/JVI.78.14.7775-7783.2004.PubMedCentralPubMedCrossRef

19.

Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol. 2004;53:459–475.PubMedCrossRef

Title: Acute Fulminant Hepatic Failure Associated with Parvovirus B19 Infection in an Immunocompetent Adult
Authors: Robert J. Huang
Brandon C. Varr
George Triadafilopoulos
Publication date: 01-11-2012
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 11/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-012-2110-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2012

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V2-Receptor Antagonist Tolvaptan

Finasteride and Methadone Use and Risk of Advanced Hepatitis C Related Liver Disease

Additional Biliary Cannulation Methods in Patients with Juxtapapillary Duodenal Diverticula

The Burden of Untreated Hepatitis C Virus Infection: A US Patients’ Perspective

May the Truth Be with You: Lubiprostone as EP Receptor Agonist/ClC-2 Internalizing “Inhibitor”

Reduced Diversity and Imbalance of Fecal Microbiota in Patients with Ulcerative Colitis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials